Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.
Luca RinaldiMaria GuarinoAlessandro PerrellaPia Clara PafundiGiovanna ValenteLuca FontanellaRiccardo NevolaBarbara GuerreraNatalina IulianoMichele ImparatoAlessio TrabuccoFerdinando Carlo SassoFilomena MoriscoAntonio AscioneGuido PiaiLuigi Elio AdinolfiPublished in: Digestive diseases and sciences (2019)
The data underline that the baseline liver stiffness measurement and ultrasound surveillance is a valuable tool for assessing the risk of HCC in cirrhotic patients undergoing the direct-acting antivirals treatment.